日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Mouse Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 protein (Prex2), partial CSB-YP660769MO
CSB-EP660769MO
CSB-BP660769MO
CSB-MP660769MO
CSB-EP660769MO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Protein winged eye (wge), partial CSB-YP660770DLU
CSB-EP660770DLU
CSB-BP660770DLU
CSB-MP660770DLU
CSB-EP660770DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Putative keratin-associated protein 20-4 (KRTAP20-4) CSB-YP660771HU
CSB-EP660771HU
CSB-BP660771HU
CSB-MP660771HU
CSB-EP660771HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Keratin-associated protein 19-4 (KRTAP19-4) CSB-YP660772HU
CSB-EP660772HU
CSB-BP660772HU
CSB-MP660772HU
CSB-EP660772HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Callithrix jacchus B-lymphocyte antigen CD19 (CD19), partial CSB-YP660773CYL
CSB-EP660773CYL
CSB-BP660773CYL
CSB-MP660773CYL
CSB-EP660773CYL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio CWF19-like protein 2 (cwf19l2), partial CSB-YP660774DIL
CSB-EP660774DIL
CSB-BP660774DIL
CSB-MP660774DIL
CSB-EP660774DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cebus apella Homeobox protein prophet of Pit-1 (PROP1) CSB-YP660775DQU
CSB-EP660775DQU
CSB-BP660775DQU
CSB-MP660775DQU
CSB-EP660775DQU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sotalia guianensis Cytochrome b (MT-CYB), partial CSB-YP660776SDAF
CSB-EP660776SDAF
CSB-BP660776SDAF
CSB-MP660776SDAF
CSB-EP660776SDAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bat coronavirus HKU3 Non-structural protein 6 (6) CSB-YP660777BFD
CSB-EP660777BFD
CSB-BP660777BFD
CSB-MP660777BFD
CSB-EP660777BFD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Leucine--tRNA ligase (leuS), partial CSB-YP660778BYN
CSB-EP660778BYN
CSB-BP660778BYN
CSB-MP660778BYN
CSB-EP660778BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis UPF0102 protein Ava_4800 (Ava_4800) CSB-YP660779BYN
CSB-EP660779BYN
CSB-BP660779BYN
CSB-MP660779BYN
CSB-EP660779BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Urease accessory protein UreE (ureE) CSB-YP660780BYN
CSB-EP660780BYN
CSB-BP660780BYN
CSB-MP660780BYN
CSB-EP660780BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Photosystem II reaction center protein K (psbK) CSB-YP660781BYN
CSB-EP660781BYN
CSB-BP660781BYN
CSB-MP660781BYN
CSB-EP660781BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Biotin synthase (bioB) CSB-YP660782BYN
CSB-EP660782BYN
CSB-BP660782BYN
CSB-MP660782BYN
CSB-EP660782BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Acireductone dioxygenase (mtnD) CSB-YP660783BYN
CSB-EP660783BYN
CSB-BP660783BYN
CSB-MP660783BYN
CSB-EP660783BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Carboxylate-amine ligase Ava_4113 (Ava_4113) CSB-YP660784BYN
CSB-EP660784BYN
CSB-BP660784BYN
CSB-MP660784BYN
CSB-EP660784BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit B (gatB) CSB-YP660785BYN
CSB-EP660785BYN
CSB-BP660785BYN
CSB-MP660785BYN
CSB-EP660785BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Probable 30S ribosomal protein PSRP-3 (Ava_3866) CSB-YP660786BYN
CSB-EP660786BYN
CSB-BP660786BYN
CSB-MP660786BYN
CSB-EP660786BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Phosphoglucosamine mutase (glmM) CSB-YP660787BYN
CSB-EP660787BYN
CSB-BP660787BYN
CSB-MP660787BYN
CSB-EP660787BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis UPF0182 protein Ava_3693 (Ava_3693), partial CSB-YP660788BYN
CSB-EP660788BYN
CSB-BP660788BYN
CSB-MP660788BYN
CSB-EP660788BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×